Cormorant Asset Management »

Onkure Therapeutics Inc-a shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $7.9M 1.8M 4.30
2024-12-31 $16M 1.8M 8.60

More positions owned by Cormorant Asset Management

Bridgebio Oncology Therapeut Com New
Abivax Sa Sponsored Ads (ABVX)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Edgewise Therapeutics (EWTX)
Bright Minds Biosciences Com New (DRUG)
Arcellx Common Stock (ACLX)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Praxis Precision Medicines I Com New (PRAX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Pharvaris N V (PHVS)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Gh Research Ordinary Shares (GHRS)

View all positions for Cormorant Asset Management

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
Shay Capital
Vanguard Group
Highbridge Capital Management
Vestal Point Capital
BlackRock
StepStone
Cantor Fitzgerald, L. P.
NEA Management Company
Carlyle
Prosight Management
Renaissance Technologies
Rangeley Capital
Tang Capital Management

View all funds holding Onkure Therapeutics Inc-a